110 related articles for article (PubMed ID: 17657172)
1. Expression of MAC30 in rectal cancers with or without preoperative radiotherapy.
Zhang ZY; Zhao ZR; Adell G; Jarlsfelt I; Cui YX; Kayed H; Kleeff J; Wang MW; Sun XF
Oncology; 2006; 71(3-4):259-65. PubMed ID: 17657172
[TBL] [Abstract][Full Text] [Related]
2. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
Wallin AR; Svanvik J; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):452-8. PubMed ID: 16626893
[TBL] [Abstract][Full Text] [Related]
3. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
Loftås P; Onnesjö S; Widegren E; Adell G; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):137-42. PubMed ID: 19289258
[TBL] [Abstract][Full Text] [Related]
4. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.
Moparthi SB; Arbman G; Wallin A; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Oncol; 2007 Jan; 30(1):91-5. PubMed ID: 17143516
[TBL] [Abstract][Full Text] [Related]
5. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy.
Knutsen A; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):149-55. PubMed ID: 15337550
[TBL] [Abstract][Full Text] [Related]
6. Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy.
Pachkoria K; Zhang H; Adell G; Jarlsfelt I; Sun XF
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):739-44. PubMed ID: 16199309
[TBL] [Abstract][Full Text] [Related]
7. Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.
Yang L; Zhang H; Zhou ZG; Yan H; Adell G; Sun XF
Clin Cancer Res; 2011 Jun; 17(11):3760-70. PubMed ID: 21531809
[TBL] [Abstract][Full Text] [Related]
8. Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer.
Xiao M; Li H; Yang S; Huang Y; Jia S; Wang H; Wang J; Li Z
J Surg Oncol; 2013 Apr; 107(5):456-62. PubMed ID: 22996179
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory infiltration, fibrosis, necrosis and mucinous content in relation to clinicopathological and molecular factors in rectal cancers with or without preoperative radiotherapy.
Knutsen A; Adell G; Sun XF
Oncol Rep; 2006 Aug; 16(2):321-7. PubMed ID: 16820910
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
11. ATM expression in rectal cancers with or without preoperative radiotherapy.
Arlehag L; Adell G; Knutsen A; Thorstenson S; Sun XF
Oncol Rep; 2005 Aug; 14(2):313-7. PubMed ID: 16012708
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MAC30 in the cytoplasm of oral squamous cell carcinoma predicts nodal metastasis and poor differentiation.
Yan BY; Wang DW; Zhu ZL; Yang YH; Wang MW; Cui DS; Zhang H; Sun XF
Chemotherapy; 2010; 56(6):424-8. PubMed ID: 21079401
[TBL] [Abstract][Full Text] [Related]
13. Expression of FXYD3 protein in relation to biological and clinicopathological variables in colorectal cancers.
Widegren E; Onnesjö S; Arbman G; Kayed H; Zentgraf H; Kleeff J; Zhang H; Sun XF
Chemotherapy; 2009; 55(6):407-13. PubMed ID: 19955746
[TBL] [Abstract][Full Text] [Related]
14. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer].
Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
17. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
19. Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy.
Stewart D; Yan Y; Mutch M; Kodner I; Hunt S; Lowney J; Birnbaum E; Read T; Fleshman J; Dietz D
Colorectal Dis; 2008 Nov; 10(9):879-86. PubMed ID: 19037929
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy.
de Heer P; Gosens MJ; de Bruin EC; Dekker-Ensink NG; Putter H; Marijnen CA; van den Brule AJ; van Krieken JH; Rutten HJ; Kuppen PJ; van de Velde CJ;
Clin Cancer Res; 2007 May; 13(10):2955-60. PubMed ID: 17504996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
